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Circulating concentrations of C-type natriuretic peptide (CNP) and a related amino terminal frag-
ment (NTproCNP) were measured at weekly intervals from preconception to 3 wk postpartum in
ewes with twins (n  8) and nonpregnant ewes (n  8). In contrast to low and stable values in
nonpregnant ewes (CNP, 0.75 0.08; NTproCNP, 22 2 pmol/liter), CNP forms increased abruptly
at 40–50 d of gestation and rose to peak values (CNP, 31  5, NTproCNP, 270  16 pmol/liter) at
about d 120. Approximately 7 d prepartum, the concentration of both CNP forms fell precipitously
to preconception values immediately postpartum. In separate studies, circulating maternal CNP
forms were positively related to fetal number at d 120. Consistent with a major contribution from
theplacenta to circulating levels, the concentrationsofCNP formswereelevated in theplacentome
(cotyledon: CNP, 18  4, NTproCNP, 52  10 pmol/g; caruncle: CNP, 13  3, NTproCNP, 31  6
pmol/g) and much higher than those of intercaruncular uterine tissue (CNP, 0.19  0.05, NT-
proCNP, 0.98 0.2 pmol/g) in late-gestation ewes (P 0.001, n 4). These distinctive patterns of
maternal plasma CNP forms, positive relation with fetal number, and greatly elevated protein
concentrations in the placentome demonstrate the hormone’s strong relation to placental and
fetal maturation. The findings provide a firm basis for future studies of the functional role of CNP
in fetal-maternal welfare. (Endocrinology 150: 4777–4783, 2009)
C-type natriuretic peptide (CNP), a member of the na-triuretic peptide family of structurally related pep-
tides, is a paracrine/autocrine growth factor with impor-
tant roles in cardiovascular homeostasis and skeletal
development. CNP and its receptor, natriuretic peptide
receptor-B, have also been identified in uterine and pla-
cental tissues and in both male and female gonads (re-
viewed in Ref. 1).Moreover, inmice, uterine CNPmRNA
expression is stimulated by estradiol (2), and CNP con-
centration in ovarian tissues fluctuates with the estrous
cycle (2). These findings suggest that CNP may be of spe-
cial importance in female reproductive biology.
Recent studies by Prickett et al. (3) showed that mater-
nal circulating concentrations of CNP are remarkably
increased (some 50-fold) in late gestation ewes when
compared with nonpregnant control sheep. Plasma con-
centrations of the (presumably) biologically inactive form
of CNP, amino-terminal proCNP (4) (NTproCNP), were
also elevated at least 10-fold. A major contribution by
uteroplacental tissues to these high systemic concentra-
tions in late gestationwas suggested by high arteriovenous
CNP gradients across the gravid uterus (3) and significant
correlationbetweenmaternalplasmaNTproCNPconcen-
tration and placental weight (3). However, the respective
contributions from placental and uterine tissues have not
been determined.
Postulating that in sheep the time course of maternal
plasma concentration of CNP forms throughout preg-
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nancy may provide insights to placental and fetal matu-
ration, we have now undertaken a longitudinal study,
from preconception to parturition, of maternal plasma
CNP forms in healthy ewes and compared the findings to
normal nonpregnant ewes studied under identical condi-
tions. The hypothesis that CNP secretion has a positive
relationship with fetal number was also tested by mea-
suring maternal circulating CNP and NTproCNP con-
centration in late gestation ewes with single, twin, and
triplet pregnancies. Finally, to clarify the likely source
of CNP in the maternal circulation, we examined the
peptide content of placental and intercaruncular tissues
from late gestation ewes.
Materials and Methods
Ethics
All procedures involving animals were approved by the Lin-
coln University Animal Ethics Committee.
Part one: longitudinal survey
Fifty-three mixed-age Coopworth, or Coopworth  South-
Hampshire cross ewes (Ovis aries) were randomly selected from
the Lincoln University Research Farm for this study. Animals
were grazed outdoors at the Lincoln University Research Farm
(Canterbury, New Zealand), with supplementary feed sup-
plied during winter. Synchronization of the estrous cycle was
achieved using intravaginal progesterone-releasing devices
(Eazi-breed type G controlled internal drug releases; Pfizer New
Zealand Ltd., Auckland) in accordance with a published proto-
col (5).On the day ofmating, eweswere randomly allocated into
two groups and run with two crayon-harnessed intact rams
(pregnant group, n  32) or with a crayon-harnessed vasecto-
mized ram (control group n  21). Five weeks later, the rams
were removed and pregnant and nonpregnant animals were run
together for the remainder of the study. Confirmation of preg-
nancywas determined by ultrasonography in early gestation and
subsequent birth of a lamb. Because conception dates were es-
timates, results are expressed in relation to actual parturition
date. Blood samples (10 ml) were collected weekly beginning
1 wk before conception until 3 wk postpartum for measure-
ment of CNP, NTproCNP, estradiol, and progesterone. Non-
fasting live weights were recorded at intervals of 2 wk.
Part two: effect of number of fetuses
Mixed-age natural-mated Suffolk, Perendale, or Corriedale
ewes from the Lincoln University Research Farmwere examined
by transabdominal ultrasonography at approximately d 94 of
pregnancy. Ewes were marked according to the number of
fetuses detected by the scanning procedure. At approximately
d120of pregnancy, eweswith a single, twin, or triplet pregnancy
(20 of each category) were selected at random and a single blood
sample was collected from each of the 60 animals.
Part three: CNP forms in utero-placental tissue
Fourmixed-ageCoopworth ewes fromtheLincolnUniversity
Research Farm carrying a single lambwere killed by captive bolt
gun on approximately d 143 of pregnancy. Before slaughter, a
maternal blood samplewas collected from each of the four ewes.
A fetal blood sample was collected immediately after slaughter.
The uterus was excised and four randomly selected placentomes
were removed from each ewe as well as four samples of inter-
caruncular uterine tissue. To determine the individual contribu-
tion of maternal and fetal tissues to placental CNP concentra-
tion, the maternal (caruncle) and fetal (cotyledon) aspects of the
placentome were separated at the time of tissue collection. This
was achieved by gently pulling on the two sides of the placen-
tome, yielding a clean separation of the two tissues. After dis-
section, the placental and uterine tissues were immediately snap
frozen in liquid nitrogen and stored at 80 C until required.
Blood samples
Blood collection was by jugular venipuncture into 10-ml
evacuated blood tubes containing EDTA as anticoagulant
(Vacutainer, Franklin Lakes, NJ) that were immediately placed
on ice. Tubes were centrifuged at 800 g for 10 min at 4 C, and
then plasmawas transferred into polystyrene tubes and stored at
20 C until required. The time from collection until centrifu-
gation did not exceed 2 h.
Extraction and characterization of peptides from
placental and uterine tissue
CNP and NTproCNP were extracted from samples of fro-
zen uterine and placental tissue (1 g) as previously described
(6). To characterize placental molecular forms, representative
tissue samples were extracted using Sep-Pak C 18 cartridges
(Waters Corp., Milford, MA) as described previously (3). Ex-
tracts were resuspended in 20% (vol/vol) acetonitrile in 0.1%
trifluoroacetic acid before size exclusion (G2000; ToyoSoda,
Tokyo, Japan) HPLC.
Hormone assays
In all cases, the entire set of samples froman individual animal
was processed in duplicate in a single assay to minimize any
impact of interassay variation. Because initial studies showed
evidence of nonparallelism at high concentrations of placental
NTproCNP, care was taken to ensure that only readouts from
validated portions of the standard curve were used.
RIA for CNP
CNP was assayed as previously described (3, 7), with minor
changes as follows: 50 l standard or sample extract was pre-
incubated with 50 l of a commercial primary rabbit antiserum
raised against proCNP (82-103) (Phoenix Pharmaceuticals Inc.,
Belmont,CA; catalogno.RAB-014-03) anddiluted to1:3000, to
which 50 l of tracer (1500 cpm) were added after a 22- to 24-h
incubation period. Within- and between-assay coefficients of
variation were 6.6 and 8.6%, respectively, at 1.1 pmol/liter. The
detection limit and EC50 for this assay were 0.4 and 6.1 pmol/
liter, respectively.
RIA for NTproCNP
NTproCNPwasmeasured as previously described (3, 4)with
the following alterations: 100 l standard/sample extract was
preincubatedwith 50l primary rabbit antiserum raised against
NTproCNP (1–15) and diluted to 1:6000 (J39), to which 50 l
of tracer (1500 cpm) were added after a 22- to 24-h incubation
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period.Within- and between-assay coefficients of variationwere
7.5 and 7.9%, respectively, at 24 pmol/liter. The detection limit
and EC50 for this assay were 1.3 and 58 pmol/liter, respectively.
Progesterone
Plasma progesterone concentration was measured in tripli-
cate 50-l aliquots byELISAas previously described (8).Within-
and between-assay coefficients of variationwere 6.1 and 14.9%,
respectively.
Estradiol
Plasma estradiol concentration was measured by RIA (E2-
Estradiol-2; Sorin Biomedica, Saluggia, Italy). Within- and be-
tween-assay coefficients of variation were 9.7 and 20%, respec-
tively, at 41 pmol/liter. The detection limit and EC50 for this
assay were 4.5 and 130 pmol/liter, respectively.
Statistical analyses
Statistical analyses were performed using Systat version 7.0
(SPSS Inc.,Chicago IL) orGenstat version10 (VSN International
Ltd., HemelHempstead, UK). Repeated-measures ANOVAwas
used to assess changes in maternal CNP and NTproCNP with
time as the independent variable. One-wayANOVAwas used to
determine adifference inhormone concentrationwithnumberof
fetuses. Bonferroni post hoc analyses were performed for both
the longitudinal and number of fetuses studies. Restricted max-
imum likelihood and a method of statistical differentials were
used to detect differences in hormone concentration in utero-
placental tissues. A paired t test was used to determine differ-
ences between maternal and fetal circulating hormone concen-
trations at d 143. Datawere log transformedwhere appropriate,
and a P  0.05 was considered statistically significant.
Results
Anexcess numberof eweswas included in the longitudinal
study to allow for animals failing to become pregnant,
death or illness of mother and/or neonates, and differing
number of fetuses. Because single fetuses were underrep-
resented, their number being insufficient to allow statis-
tical evaluation, the study groupswere confined tohealthy
twin-bearing ewes with normal pregnancy and delivery
andhealthy nonpregnant control ewes. Fromeachof these
twogroups, eight animalswere chosenat randomfor com-
pletion of hormone profiles (Figs. 1 and 2).
Live weight and birth weights of lambs
All animals used in the longitudinal study had weight
gain profiles and birth weights consistent with normal
pregnancy for Coopworth sheep on this farm.
Circulating CNP and NTproCNP concentrations
throughout pregnancy
PlasmaconcentrationsofCNPandNTproCNPincreased
significantlyduringpregnancyinewes(P0.01;Fig.1).One
week before conception, plasma CNP concentration was
0.98  0.06 pmol/liter and plasma NTproCNP concentra-
tion was 27.2 1.07 pmol/liter. In pregnant ewes, circulat-
ing concentrations of CNP and NTproCNP became signif-
icantlyelevatedaboveprepregnancyvaluesby115and110d
before parturition, respectively (ovine gestation length is
145 d) (CNP, P  0.001; NTproCNP, P  0.05). Peak
plasma concentration of CNP (31  5 pmol/liter) and
NTproCNP (270 16 pmol/liter) was observed at around
30 d before parturition, followed by a significant decline in
the concentration of both peptide forms (7 d before partu-
rition; CNP, 36%of peak, P 0.001; NTproCNP, 71%of
peak, P 0.01). Circulating CNP and NTproCNP concen-
trations returned to prepregnancy values immediately after
parturition (P 0.1).
Innonpregnant ewes, theplasmaconcentrationofCNP
and NTproCNP (mean SEM) was 0.75 0.08 and 22
2pmol/liter, respectively.Therewasa small but significant
fall in plasma concentration of CNP (P  0.05) and NT-
proCNP (P  0.001) during the study period (Fig. 1).
Circulating estradiol and progesterone
concentrations in pregnant ewes
Mean plasma estradiol concentration declined steadily
during the first trimester (Fig.2A).Thereafter thevalues fluc-
tuated but there was a sustained elevation during the final 3
wk of pregnancy before falling sharply at parturition. In-
FIG. 1. Mean ( SEM) plasma NTproCNP (A) and CNP (B)
concentration in twin-bearing pregnant (F) and nonpregnant (E) ewes
(n  8). Day of pregnancy refers to pregnant animals. *, Significant
difference from prepregnancy baseline; #, significant difference
between the final 2 wk of gestation. Parturition occurred at d 0.
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crease in mean plasma progesterone concentration com-
menced soon after midgestation, peaking approximately
23 d before parturition, after which themean concentration
declined progressively (Fig. 2B). After parturition both es-
tradiol and progesterone were barely detectable in the ma-
ternal venous plasma.
Effect of fetal number
The number of fetuses had a significant positive effect
on the concentration of circulating CNP forms, being
higher in triplet pregnancies (CNP, P 0.001; NTproCNP,
P  0.001) (Fig. 3).
Identity and concentration of CNP forms
in utero-placental tissues
When subjected to size exclusion HPLC/RIA, a major
peak of immunoreactive CNP eluted in a position consistent
with CNP-53 (Fig. 4A). A smaller peak (fractions 31–33)
consistentwithCNP-22wasalso identified.As shown inFig.
4B, amajor peak of immunoreactive proCNP1-15 eluted in
a position consistentwith the 5-kDa (or closely similar) ami-
noterminal fragment (proCNP 1-50). A smaller (unidenti-
fied)andlaterelutingpeakwasalsopresent.Theearlyeluting
shoulder (fractions22–25)of immunoreactivematerial iden-
tified in both Fig. 4, A and B, is consistent with the presence
of proCNP (1–103).
CNP and NTproCNP concentrations in the placentome
were significantly higher than in uninvolved uterine tissue
(CNP, P 0.001; NTproCNP, P 0.001) (Fig. 5). Within
the placentome, the concentration of both CNP forms was
significantlyhigher in the fetal cotyledoncomparedwithma-
ternal caruncle (CNP, P  0.05; NTproCNP, P  0.001)
(Fig. 5). Plasma CNP and NTproCNP concentrations were
higher in the maternal compared with fetal circulation at
around d 143 of pregnancy (CNP, P  0.01, NTproCNP,
P 0.01) (Fig. 6).
Discussion
This report constitutes the first longitudinal study of mater-
nal circulatingCNP forms throughoutpregnancy inany spe-
cies. In confirming previous findings of greatly raised con-
centrations in late gestation in the ewe (3), the present results
extend our knowledge of CNP’s participation in ovine preg-
nancy by showing an abrupt increase coinciding with pla-
centation followed by a progressive rise until near term and
amarkeddecline inmaternal concentrations during the final
week of pregnancy. In addition, we show a direct relation-
shipbetweenmaternal concentrationofCNPformsandfetal
number and identify theplacenta as themajor contributor to
FIG. 2. Mean ( SEM) plasma estradiol (A) and progesterone (B) in
twin-bearing pregnant ewes (n  8) throughout the course of
gestation. Parturition occurred at d 0.
FIG. 3. Mean ( SEM) plasma concentration of NTproCNP (A) and CNP
(B) at around d 120 of gestation in ewes carrying one (n  23), two
(n  20), or three (n  17) fetuses.
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the high gradient across the gravid uterus. These observa-
tions strongly support a role for CNP in placental and fetal
maturation and serve as a basis for future in vivo studies of
CNP’s functional role.
In ewes bearing twins, venous plasmaNTproCNP con-
centration increased abruptly toward the end of the first
trimester in strong contrast to the much lower and un-
changing concentration of NTproCNP in nonpregnant
adult control animals.The initial rateof increase inplasma
NTproCNP concentration was greater than that of CNP,
but increases in both forms slowed about 90–60 d before
parturition (at a gestational age of 55–85 d). Of interest,
similar patterns of change are observed in plasma nitric
oxide (9) and may be associated with reduced estrogen
production during the same period (10). After midgesta-
tion, the rate of increase in maternal CNP concentration
exceeded that of NTproCNP. Whether these differential
changes in CNP forms relate to reduced activity of deg-
radative pathways, including natriuretic peptide recep-
tor-C (which is down-regulated in uterine arteries in late
gestation) (11) or neprilysin or possibly associated with
the phase of rapid fetal growth is unclear. Although CNP
synthesis is high in the fetus, any contribution of the fetus
itself to maternal levels is unlikely because the fetal lamb
plasma concentration of CNP (3.3 0.5 pmol/liter, Fig. 6)
is much lower than maternal levels and appears to be reg-
ulated independently (3).
Our study was not designed to determine the mecha-
nisms underlying the dramatic changes we observe in ma-
ternal concentrations nor their functional consequences.
Nonetheless, the time sequence, close correlation of
plasma concentration of CNP forms with fetal number,
and the greatly elevated CNP concentrations within the
placentome all point to the placenta as a major source. Of
note, the initial increase in maternal NTproCNP concen-
tration corresponds to the phase of maximum placental
growth and invasion of thematernal stroma (12). Inmice,
we have shown abundant CNP expression closely associ-
ated with the maternal blood vessels of the placenta (13),
possibly initiated by increases in shear stress (14). This
localization suggests a role for the hormone in angiogen-
esis (15, 16) and vasodilation (17). Indeed, later in gesta-
tion it seems likely that both the local (auto/paracrine)
actions within placenta and uterus (1, 2) as well as endo-
crine contributions from high circulating CNP concentra-
tions (18) all contribute to the massive increase in utero-
placental blood flow associated with the pregnant state
(11, 19). In this context, increased estrogen production is
known to be important in maintaining vasodilation (20).
The effects of estrogens are mediated in part by nitric ox-
ide, but the changes in this pathway are considered to be
insufficient to account for the increases in uterine blood
FIG. 5. Mean ( SEM) concentration of NTproCNP (A) and CNP (B) in
the uterus, maternal placenta (caruncle), and fetal placenta (cotyledon)
of single-bearing ewes at around d 143 of gestation (n  4).
FIG. 4. Immunoreactive (ir) NTproCNP (A) and CNP (B) size exclusion
HPLC profiles of ovine placental extract from d 143 of gestation.
Column void volume (V0) and elution positions of molecular markers
are shown by arrows.
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flow observed in late gestation (20). Estradiol increases
CNP gene expression inmurine uterus (2) and, as recently
reported by us, also stimulates plasmaCNP forms in adult
(nonpregnant) ewes (21). Together these findings raise the
possibility that some of estradiol’s actions on uterine
blood flowmaybemediatedbyCNP.Whereas thismaybe
true after midgestation, it is notable that the initial in-
creases in NTproCNP occur during a period of declining
plasma estradiol concentration, making it unlikely that
estradiol is themain driver ofCNP synthesis in pregnancy.
Our finding of significantly higher CNP protein concen-
trations in placental comparedwith uterine tissue in late ges-
tation is consistent with other reports in mice (22). Impor-
tantly, analyses using HPLC-RIA confirmed that the
molecular forms in placental tissues at term are closely sim-
ilar to those previously reported in the ovine maternal cir-
culation (3). The fact that in sheep, unlike humans,maternal
plasmaCNPappears to reflect placental synthesis of thehor-
mone offers a novel approach to the study of placental CNP
regulation in vivo. Furthermore, surgical techniques isolat-
inguterine fromuteroplacental vein collections shouldallow
studies of the factors regulating CNP production in these
individual tissues(andits functionalrole) inthe livinganimal.
Of note, cotyledonary concentrations of both CNP forms
exceed those in the caruncle, suggesting thatCNP, like ovine
placental lactogen (23),maybe synthesizedby the fetal binu-
cleate cell (syncytiotrophoblasts). These cells migrate across
the placenta to release the products into the maternal circu-
lation. Such a fetal maternal gradient within the placenta
would also be consistent with recent results from our labo-
ratory (24), showing that the fetal concentrations of CNP
forms inmatchedumbilical andvenousplasmaare similar in
late gestation.
A striking observation in the present study is the pre-
cipitous decline in concentrations of bothCNP forms dur-
ing the finalweekofpregnancy.The time sequenceof these
changes coincides with the period of rapid hypothalamus-
pituitary-adrenal activation in the fetus (25). The rise in
fetal plasma cortisol concentration in lambs commences
around 15 d before delivery (25) and is associated with
progressive induction of placental 17-hydroxylase and
fall in maternal plasma progesterone as observed in our
study. Conceivably the upsurge in fetal cortisol secretion
in the final 3–5 d (25) may be sufficient at the placental
tissue level to down-regulate CNP expression. We have
shown previously that glucocorticoids can rapidly inhibit
CNP synthesis in vivo (6, 26). Whether similar inhibition
can occur at the much lower concentrations of glucocor-
ticoids attained near term awaits further study. In any
event, the current findings suggest that inhibiting CNP
once the fetus is mature may be an important step in pre-
paring for parturition, i.e. by restoring myometrial con-
tractility (1, 27) and reducing vasodilation (17) and po-
tential blood loss associated with placental separation.
The current findings in pregnant ewes, together with
evidence of reciprocal changes in fetus (in which CNP
falls) and ewe (in which CNP rises) during nutritional
stress (3), strongly support the view that CNP is carefully
regulated in pregnancy and that change in maternal
plasma CNP concentration, at least in sheep, may reflect
local uteroplacental secretion and fetal distress. On this
hypothesis, higher maternal circulating CNP concentra-
tion with increasing fetal number in ewes at d 120 gestation
may be seen as an adaptive change to caloric restriction.
This view is reinforced by our finding that the fetal plasma
CNPconcentration is lower in a twinwhencomparedwith
that in a single fetus (3). In late-gestation ewes carrying
twin and triplet fetuses, nutritional requirements are 120
and 140% above maintenance, respectively (28), which if
not met, will result in caloric restriction. Similar mecha-
nismsmay be the basis for highermaternal concentrations
of NTproCNP, and lower fetal values, in women present-
ing with preeclampsia when compared with normal preg-
nant women at term (29). Clearly these hypotheses now
require experimental support, possibly using models of
placental insufficiency.
In conclusion, the distinctive pattern of maternal con-
centrationsofCNP forms (abrupt rise at the endof the first
trimester and sudden prepartum fall), positive relation
FIG. 6. Mean ( SEM) plasma concentration of NTproCNP (A) and CNP
(B) in single-bearing ewes and their fetuses at around d 143 of
pregnancy (n  4).
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with fetal number, and greatly elevated concentrations in
the placentome demonstrate the hormones’ strong rela-
tion to placental and fetal maturation. Together the find-
ings provide a basis for elucidating the functional role of
CNP in fetal-maternal welfare.
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